http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2233646-C1

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
filingDate 2003-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2004-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d180fc0d24f32b92609d5555aa4efbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f316f8dcb0f8f58510c01aeaefe8f04
publicationDate 2004-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2233646-C1
titleOfInvention Method for esthetic correction of inferior eyelids
abstract FIELD: medicine, surgery. n SUBSTANCE: one should make inclined incision of skin by capturing muscular layer coming by leaving against external ocular angle along one of the patient's wrinkles. One should separate cutaneous-muscular layer up to the level of tarso-orbital fascia. Then one should perform horizontal incision of skin along ciliary edge towards internal ocular angle. Excessive parts of tarso-orbital fascia should be collected into a fold coming from external to internal ocular angle being parallel to ciliary edge. Then this fold should be folded along the whole length inside by adapting its edges with blanket suture out of absorbable material. Excessive skin should be dissected as a strip along superior edge of cutaneous-muscular layer and as a triangle - at external ocular angle. Sutures should be applied onto cutaneous-muscular incision. In peculiar case, inclined cutaneous-muscular incision should be performed by leaving about 1.5-2 mm against external ocular angle being 7-12 mm length. In peculiar case, excessive parts of tarso-orbital fascia should be folded inside as a fold of 3-6 mm width and 2-2.5 mm length depending upon the degree of fascial tension. In peculiar case, one should apply biosorb 6-0 to adapt fold's edges of tarso-orbital fascia. In peculiar case, one should dissect a strip of muscular tissue of 0.5-1.0 mm width along superior edge of cutaneous-muscular fragment. The present innovation enables to decrease traumaticity level and prevent relapses of fatty hernias. n EFFECT: higher efficiency of correction. n 4 cl, 2 ex
priorityDate 2003-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12449
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451216657

Total number of triples: 13.